| HOME >> BIOLOGY >> TECHNOLOGY |
To support its development of oncology diagnostic technology, Cernostics is working closely with Geisinger Health System, a $2.3 billion integrated health services organization based in Pennsylvania. Supported by Geisinger, Cernostics gains access to a clinical setting on which to create and validate pathology solutions, including a large tumor bank linked to well-annotated, deep and longitudinal clinical information.
About Definiens
Definiens is a leading Health Image Intelligence™ company that develops software solutions for biomedical image analysis, data mining and clinical decision support. The company's software analyzes images from cell-based assays, whole tissue slides and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics and therapy. By automating analysis workflows and generating new knowledge, Definiens provides pharmaceutical and biotechnology companies, research institutions, clinical service organizations and medical professionals with deeper insights, faster results and better decision support. Harnessing the power of image intelligence, Definiens supports personalized medicine and aims to significantly improve the quality of patients' lives.
Definiens is headquartered in Munich, Germany, and has offices throughout the United States. Further information is available at www.definiens.com.
Definiens – from images to clinical decisions.
Definiens, Definiens Cognition Network Technology, Definiens Cellenger, Definiens Tissue Studio, Definiens LymphExpert, Enterprise Image Intelligence, Health Image Intelligence and Understanding Images are trademarks or register
'/>"/>
| SOURCE Definiens Copyright©2010 PR Newswire. All rights reserved |